These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Genetic control of dopamine receptors in mouse caudate nucleus: relationship on cataleptic response to neuroleptic drugs. Fink JS; Swerdloff A; Reis DJ Neurosci Lett; 1982 Oct; 32(3):301-6. PubMed ID: 6129603 [No Abstract] [Full Text] [Related]
45. The differential coupling mechanism of dopamine D-2 receptor subtypes: importance for the actions of neuroleptic drugs. Memo M; Missale C; Pizzi M; Spano PF Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():458A-459A. PubMed ID: 1354049 [No Abstract] [Full Text] [Related]
46. The substituted benzamides--a novel class of dopamine antagonists. Jenner P; Marsden CD Life Sci; 1979 Aug; 25(6):479-85. PubMed ID: 40086 [No Abstract] [Full Text] [Related]
47. Identification of dopamine receptors in the rat retina. Schaeffer JM Exp Eye Res; 1980 Apr; 30(4):431-7. PubMed ID: 7449870 [No Abstract] [Full Text] [Related]
49. Chronic neuroleptic treatment specifically alters the number of dopamine receptors in rat brain. Theodorou A; Gommeren W; Clow A; Leysen J; Jenner P; Marsden CD Life Sci; 1981 Apr; 28(14):1621-7. PubMed ID: 7242249 [No Abstract] [Full Text] [Related]
50. New selective dopamine D-2 antagonists as antipsychotic agents. Pharmacological, chemical, structural and theoretical considerations. Högberg T; Rämsby S; Ogren SO; Norinder U Acta Pharm Suec; 1987; 24(6):289-328. PubMed ID: 2898864 [No Abstract] [Full Text] [Related]
51. Heterogeneity and regulation of central dopamine receptor subtypes studied by cDNA cloning methodology. Sokoloff P; Martres MP; Giros B; Bouthenet ML; Schwartz JC Neurochem Int; 1992 Mar; 20 Suppl():27S-32S. PubMed ID: 1365440 [No Abstract] [Full Text] [Related]
52. The window of vulnerability in the ontogeny of the dopamine receptor. Miller JC; Friedhoff AJ Psychopharmacol Bull; 1985; 21(3):683-5. PubMed ID: 2863851 [No Abstract] [Full Text] [Related]
53. Multiple dopamine receptors. Proceedings of a workshop at the Ninth Society for Neuroscience Annual Meeting, Atlanta, Georgia, November 1979. Commun Psychopharmacol; 1979; 3(6):383-470. PubMed ID: 44692 [No Abstract] [Full Text] [Related]
54. [Dopaminergic receptors in the cardiovascular system: their biochemical characterization and pharmacological importance]. Missale C; Liberini P; Lombardi C; De Cotiis R; Memo M; Spano PF Cardiologia; 1987 Dec; 32(12):1613-6. PubMed ID: 3329021 [No Abstract] [Full Text] [Related]
55. [Pharmacologic interactions in dopaminergic receptors in the central nervous system (author's transl)]. Munõz C Rev Med Chil; 1978 Mar; 106(3):221-5. PubMed ID: 663464 [No Abstract] [Full Text] [Related]
56. [Dopaminergic receptors in the brain]. Alexandrová M Cesk Fysiol; 1984; 33(3):227-40. PubMed ID: 6147203 [No Abstract] [Full Text] [Related]